C1-esterase-inhibitor treatment at early reperfusion of hemorrhagic shock reduces mesentry leukocyte adhesion and rolling

Microcirculation. 2001 Dec;8(6):427-33. doi: 10.1038/sj/mn/7800115.

Abstract

Objective: Complement activation probably plays a pathogenic role in multiple organ failure in shock. This study evaluates the effects of C1-esterase-inhibitor treatment on leukocyte-endothelial interaction in the mesenteric microcirculation in hemorrhagic shock.

Methods: Rats underwent median laparotomy and exteriorization of an ileal loop for intravital microscopy of the mesenteric microcirculation. Volume controlled hemorrhagic shock was provoked by arterial blood withdrawal (2.5 mL/100 g body wt. for 60 minutes) followed by a 4-hour reperfusion period. C1-INH (100 IU/kg body wt. i.v.) or 0.9% NaCl i.v. were administered as a bolus at the beginning of reperfusion. Reperfusion time mimicked a "pre-hospital" phase of 30 minutes followed by a quasi "in-hospital" phase of 3.5 hours. The "in-hospital" phase was initiated by substitution of blood followed by fluid resuscitation with normal saline.

Results: Application of C1-INH markedly reduced rolling and adherent leukocytes to numbers approaching baseline values. Vmax and shear rate of the mesenteric microcirculation improved in both groups after reperfusion with a trend to higher values in the C1-INH group (n.s. p = 0.08).

Conclusion: C1-INH applied in a bolus dose of 100 IU/kg body wt. i.v. abrogated enhanced leukocyte adhesion and rolling in the mesenteric microcirculation after hemorrhagic shock. Single bolus treatment with a complement inhibitor may provide clinical benefit when applied at an early stage of reperfusion during hemorrhagic shock.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Adhesion / drug effects
  • Chemotaxis, Leukocyte / drug effects
  • Complement C1 Inactivator Proteins / pharmacology
  • Complement C1 Inactivator Proteins / therapeutic use*
  • Endothelium, Vascular / cytology*
  • Hemodynamics / drug effects
  • Ileum / blood supply
  • Kinetics
  • Leukocytes / drug effects*
  • Leukocytes / pathology
  • Male
  • Microcirculation / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion
  • Shock, Hemorrhagic / drug therapy*
  • Splanchnic Circulation / drug effects

Substances

  • Complement C1 Inactivator Proteins